相关实验视频

Updated: Jan 8, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

通过TET2进行表观遗传重编程,可以防止中间化,并恢复血管光滑肌细胞身份

Bob S L Lee¹, Joshua K Dunn², Cassandra Liang²

¹Vascular Epigenetics Laboratory, Victor Chang Cardiac Research Institute, Sydney, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

JACC. Basic to translational science

|December 12, 2025

概括

Tet2是一种DNA脱甲基酶,可以防止血管光滑肌肉细胞的转基因分化和化. 用甲酸盐增强Tet2活性可降低小鼠的大动脉化,这表明Tet2重新激活是心血管疾病的治疗策略.

科学领域:

表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
血管生物学血管生物学
心血管疾病心血管疾病

背景情况:

血管化是心血管病理的一个标志,源于血管光滑肌细胞 (VSMC) 的骨质变异.
表观遗传修饰在调节VSMC表型和血管化方面发挥着至关重要的作用.
Tet2是一种DNA脱甲基酶,涉及表观遗传调节,但其在血管化中的作用需要进一步阐明.

研究的目的:

调查Tet2作为表观遗传调节者的作用,防止VSMC骨质变异和血管化.
为了确定Tet2损失对VSMC表型和大动脉化的影响.
评估增强Tet2活性在缓解血管化的治疗潜力.

主要方法:

生成了特定于VSMC的Tet2淘汰赛小鼠模型.
在淘汰赛小鼠中评估了VSMC分化,亡和巨细胞透.
量化了中间大动脉化,并分析了大动脉结构.
向野生型小鼠注射高剂量的酸盐以增强Tet2活性,并评估其对化的影响.

主要成果:

在VSMC中失去Tet2促进了骨质生分化和亡.
Tet2 缺乏导致Trem2 高的巨细胞的透增加和显著的中枢大动脉化.
在小鼠中,高剂量的甲酸盐剂量显著降低了血管化,并保留了大动脉结构.
确定了Tet2活动作为一个关键的表观遗传机制,防止VSMC转差.

结论:

Tet2是一种关键的表观遗传调节剂,可以防止VSMC的骨质变异,从而抑制血管化.
Tet2 缺乏会加剧血管化和相关的病理.
例如,通过高剂量 Askorbate 增强 Tet2 活性,是预防或逆转心血管疾病中血管化的有前途的治疗策略.

关键词:

亚甲酸盐是一种亚酸盐.表观遗传学是指表观遗传学.血管化血管化血管光滑肌肉细胞的细胞.

更多相关视频

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

相关概念视频

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...